Riskpilot← Back to searchSign inGet full accessHERALK AS
ASActiveOrg 919802790General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2022
NOK 0
EBITDA margin
—
Equity ratio
94.6%
Financial strength
Net profit 2022
NOK 0
-100% vs 2021
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | -100% |
| Total assets | NOK 8,3M | +0% |
| Equity | NOK 7,8M | +0% |
| Employees | 0 | — |
Legal name
HERALK AS
Org number
919802790
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. oktober 2017
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder eller daglig leder hver for seg.
Company purpose
Drift av medisinske plattformer (medtech), samt hva hermed står i forbindelse og deltagelse i andre selskaper med lignende formål.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −6 | 0 | 0 | −3 | −1 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | 0 | 0 | −3 | −1 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 7 792 | 0 |
| Profit before tax | −6 | 0 | 0 | −3 | 7 791 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −6 | 0 | 0 | −3 | 7 791 | 0 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Total assets | 24 | 24 | 24 | 2 820 | 8 257 | 8 257 |
| Equity | 24 | 24 | 24 | 20 | 7 810 | 7 810 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 2 800 | 446 | 446 |
| Total debt | 0 | 0 | 0 | 2 800 | 446 | 446 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20172022
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20172022
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20172022
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20172022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172022
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20172022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-10-06 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lommeboken As | Company | 20.0% | 20.0% | 2023 |
Aaa Investment As | Company | 20.0% | 20.0% | 2023 |
Sandev As | Company | 20.0% | 20.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lommeboken As
HERALK AS Board members of HERALK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Niels Ruben Ravnaas | Chief Executive Officer | 0 companies |
| Roger Sebastian Sedal | Chairman | 0 companies |
| Trond Arne Fjellman | Board of Directors | 0 companies |
| Erik Elnes | Chairman | 0 companies |
| Ole Syvert Dalan | Chairman | 0 companies |
| Hawra Alyasiri | Board of Directors | 0 companies |
| Espen Sandall | Board of Directors | 0 companies |